Citation Impact

Citing Papers

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: Prospective randomized controlled trial
2006
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Differential Regulation of Amidase- and Formamidase-mediated Ammonia Production by the Helicobacter pylori Fur Repressor
2003
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
2009
Gastric cancer
2016 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
A Prospective Randomized Comparative Trial Showing That Omeprazole Prevents Rebleeding in Patients With Bleeding Peptic Ulcer After Successful Endoscopic Therapy
1998
Myocardial Infarction in Critically III Patients Presenting With Gastrointestinal Hemorrhage
1998
Long-Term Results of a Randomized Prospective Study Comparing Medical and Surgical Treatment of Barrett’s Esophagus
2003
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults
2010
Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy
2000
Host-Bacterial Interactions in Helicobacter pylori Infection
2008
Current role of acid suppressants in Helicobacter pylori eradication therapy
2001
Changes of gastric mucosal architecture during long‐term omeprazole therapy: results of a randomized clinical trial
2006
Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism
2000
Functional Gastroduodenal Disorders
2006 Standout
Empirical Therapy versus Diagnostic Tests in Gastroesophageal Reflux Disease (A Medical Decision Analysis)
1998
Inflammation, atrophy, and gastric cancer
2007
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
2003
Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding*
2004
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
The Intriguing Relationship of <i>Helicobacter pylori</i> Infection and Acid Secretion in Peptic Ulcer Disease and Gastric Cancer
2011
Endoscopic Therapy for Bleeding Ulcers: An Evidence-Based Approach Based on Meta-Analyses of Randomized Controlled Trials
2008
Ulcerative Colitis
2011 Standout
Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia
2002
Drug Insight: aminosalicylates for the treatment of IBD
2007
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique
2005
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Screening for Colorectal Neoplasia with CT Colonography: Initial Experience from the 1st Year of Coverage by Third-Party Payers
2006
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
2008 Standout
Interleukin 1β polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan
2002
Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting
2006
NF-κB in cancer: from innocent bystander to major culprit
2002 Standout
Divergent trends for gastric cancer incidence by anatomical subsite in US adults
2011
Seroconversion for Helicobacter pylori
1993
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2007
Effect of oral esomeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers
2006
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
The Role of Helicobacter pylori in Patients with Hypothyroidism in Whom Could Not be Achieved Normal Thyrotropin Levels Despite Treatment with High Doses of Thyroxine
2011
Informed decision-making in colorectal cancer screening using colonoscopy or CT-colonography
2013
High‐dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost‐effectiveness analysis
2004
False Negative Urea Breath Tests with H2‐Receptor Antagonists: Interactions Between Helicobacter pylori Density and pH
2004
A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer
2006
Double gastric infection with Helicobacter pylori and non‐Helicobacter pylori bacteria during acid‐suppressive therapy: increase of pro‐inflammatory cytokines and development of atrophic gastritis
2001
Esophageal Cancer
2003 Standout
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
The gastric transitional zones: Neglected links between gastroduodenal pathology and Helicobacter ecology
1999
Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association?
2000
Trends in Management and Outcomes of Acute Nonvariceal Upper Gastrointestinal Bleeding: 1993–2003
2006
Risk Assessment and Outpatient Management in Bleeding Peptic Ulcer
2005
Omeprazole and CYP2C19 polymorphism: effects of long‐term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders
2000
Helicobacter pylori Reduces Intracellular Glutathione in Gastric Epithelial Cells
2000
Marshall and Warren Lecture 2009: Peptic Ulcer Bleeding: An expedition of 20 years from 1989–2009
2009
Systematic Review of the Predictors of Recurrent Hemorrhage After Endoscopic Hemostatic Therapy for Bleeding Peptic Ulcers
2008
Ulcer Prevention in Long-term Users of Nonsteroidal Anti-inflammatory Drugs
2002
Helicobacter pylori and reflux disease
2003
Risk scoring systems to predict need for clinical intervention for patients with nonvariceal upper gastrointestinal tract bleeding
2007
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth
2001
Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis
2015
Proton pump inhibitors versus H2‐antagonists: a meta‐analysis of their efficacy in treating bleeding peptic ulcer
2001
The Long‐term Impact of Helicobacter pylori Eradication on Gastric Histology: a Systematic Review and Meta‐analysis
2007
The Changing Epidemiology of Gerd: Geography and Helicobacter Pylori
2003
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
2011
Use and impact of early endoscopy in elderly patients with peptic ulcer hemorrhage: a population-based analysis
2009
Aptamers as therapeutics
2010 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Changing Patterns of Helicobacter pylori Gastritis in Long‐Standing Acid Suppression
2000
Third Chinese National Consensus Report on the management of Helicobacter pylori infection1
(August 2007, Lushan, Jiangxi Province, China)
2008
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease
2001
Host Response and Vaccine Development to Helicobacter pylori Infection
1999
Helicobacter pylori: host genetics and disease outcomes
2008
The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education
1990 Standout
Oesophageal carcinoma
2013 Standout
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
1998
Early Intensive Resuscitation of Patients With Upper Gastrointestinal Bleeding Decreases Mortality
2004
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Esomeprazole — enhanced bio‐availability, specificity for the proton pump and inhibition of acid secretion
2003
A risk score system for identification of patients with upper-GI bleeding suitable for outpatient management
2004
Cost‐effectiveness of colorectal cancer screening with computed tomography colonography
2007
Maintenance Treatment Is Not Necessary After Helicobacter pylori Eradication and Healing of Bleeding Peptic Ulcer
2003
Acid Suppression and Chemoprevention in Barrett’s Oesophagus
2004
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
1998
Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole
1999
Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori
2010
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
2018 Standout
Embolization as a First Approach with Endoscopically Unmanageable Acute Nonvariceal Gastrointestinal Hemorrhage
2001
Review article: Helicobacter pylori eradication for the prevention of gastric cancer
2007
Non‐Helicobacter pylori bacterial flora during acid‐suppressive therapy: differential findings in gastric juice and gastric mucosa
2001
Inflammation and cancer: back to Virchow?
2001 Standout
Ulcerative colitis
2016 Standout
HELICOBACTER PYLORI AND GASTROESOPHAGEAL REFLUX DISEASE
1999
The Role of Interleukin‐1Beta and Other Potential Genetic Markers as Indicators of Gastric Cancer Risk
2003
Epidemiology of Premalignant Gastric Lesions: Implications for the Development of Screening and Surveillance Strategies
2007
Gastric cancer
2020 Standout
Helicobacter pyloriInfection
2002 Standout
Histological changes of gastric mucosa afterHelicobacter pylorieradication: A systematic review and meta-analysis
2014
Endoscopic clipping versus injection and thermo-coagulation in the treatment of non-variceal upper gastrointestinal bleeding: a meta-analysis
2007
Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis
2003
A risk score to predict need for treatment for uppergastrointestinal haemorrhage
2000 Standout
Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report
2002
Pathophysiological effects of long-term acid suppression in man
1995
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
2004 Standout
Acute Upper Gi Bleeding: Did Anything Change?
2003
The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade
2002
The health economics of Helicobacter pylori infection
2007
Guidelines for the management of Helicobacter pylori infection
1998
Systematic review: Heliocobacter pylori infection and impaired drug absorption
2008
Early events in proton pump inhibitor‐associated exacerbation of corpus gastritis
2003
Validity of the Rockall scoring system after endoscopic therapy for bleeding peptic ulcer: a prospective cohort study
2006
The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array
2009
One‐week clarithromycin triple therapy regimens for eradication of Helicobacter pylori
1998
Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas)
2006
Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection
2009
Potential adverse effects of proton pump inhibitors
2008
The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting
2004
Management of patients with nonvariceal upper gastrointestinal hemorrhage before and after the adoption of the Rockall score, in the Italian Gastroenterology Units
2007
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths
2012 Standout
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer
2003
Continuous Infusion of Pantoprazole versus Ranitidine for Prevention of Ulcer Rebleeding: A U.S. Multicenter Randomized, Double-Blind Study
2006
Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia
2000
Chemoprevention of Oesophageal Cancer and the AspECT Trial
2008
Randomized Double-Blind Factorial Trial of Three Treatments To Reduce the Prevalence of Precancerous Gastric Lesions
2006
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
2010
Gerontology as oncology. Research on aging as the key to the understanding of cancer
1991
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial
2002
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
National and Local Trends in CT Colonography Reimbursement: Past, Present, and Future
2007
Effect of Intravenous Omeprazole on Recurrent Bleeding after Endoscopic Treatment of Bleeding Peptic Ulcers
2000
Epidemiology of acute upper gastrointestinal bleeding
2008
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Gastroesophageal Reflux Disease
1996
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Rapid Loss of Motility of Helicobacter pylori in the Gastric Lumen In Vivo
2005
Quality Indicators for Colonoscopy
2014
Changes in Helicobacter pylori‐induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease
1998
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
2016
Meta-Analysis: Computed Tomographic Colonography
2005
Review article:Helicobacter pyloriand gastro‐oesophageal reflux disease—clinical implications and management
1999
Double-Contrast Barium Enema: Use in Practice and Implications for CT Colonography
2006
Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn?
2009
Management of Peptic Ulcers: Emerging Issues
2000
Decision aids for people facing health treatment or screening decisions
2017 Standout
The effect of Helicobacter pylori eradication on gastro‐oesophageal reflux
1999
ICOS+Foxp3+TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori
2016 StandoutNobel
Consensus Recommendations for Managing Patients with Nonvariceal Upper Gastrointestinal Bleeding
2003
A Comparison of Omeprazole and Placebo for Bleeding Peptic Ulcer
1997 Standout
CanadianHelicobacter pyloriConsensus Conference
1998
Quality Indicators for Colonoscopy
2006
Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding
2010
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Interventions for enhancing medication adherence
2014 Standout
Intravenous Esomeprazole for Prevention of Recurrent Peptic Ulcer Bleeding
2009
Cancer statistics, 2016
2016 Standout
Cancer statistics, 2015
2015 Standout
Quality indicators for colonoscopy
2014 Standout
A Sampling of Canadian Practice in Managing Nonvariceal Upper Gastrointestinal Bleeding before Recent Guideline Publication: Is there Room for Improvement?
2005
Characteristics of Advanced Adenomas Detected at CT Colonographic Screening: Implications for Appropriate Polyp Size Thresholds for Polypectomy Versus Surveillance
2007
Canadian Helicobacter Study Group Consensus Conference: Update on the Approach to Helicobacter Pylori Infection in Children and Adolescents – an Evidence-Based Evaluation
2005
Canadian Consensus Conference on the Management of Gastroesophageal Reflux Disease in Adults – Update 2004
2005
Guidelines in the management of Helicobacter pylori infection in Japan
2003
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
The RNA Component of Human Telomerase
1995 StandoutScienceNobel
Cost-effectiveness Analysis between Primary and Secondary Preventive Strategies for Gastric Cancer
2007
Comparison of three different risk scoring systems in non-variceal upper gastrointestinal bleeding
2004
Helicobacter pylori modulation of gastric acid.
2000
The Role of Rapid Endoscopy for High-Risk Patients with Acute Nonvariceal Upper Gastrointestinal Bleeding
2007
Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection
2013
Changes in Helicobacter pylori‐induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro‐oesophageal reflux disease
1998
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel

Works of P. Snel being referenced

Use of Omeprazole in the Management of Reflux Oesophagitis Resistant to H2-receptor Antagonists
1989
Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial
2003
Influence of variations in sample handling on SELDI‐TOF MS serum protein profiles for colorectal cancer
2008
Effect of long-term treatment with omeprazole on serum gastrin and serum group A and G pepsinogens in patients with reflux esophagitis
1990
Effect of Omeprazole on the Outcome of Endoscopically Treated Bleeding Peptic Ulcers Randomized Double-Blind Placebo-Controlled Multicentre Study
1997
Computed tomographic colonography compared with colonoscopy in patients at increased risk for colorectal cancer
2004
Omeprazole Versus High-Dose Ranitidine in Mild Gastroesophageal Reflux Disease: Short- and Long-Term Treatment
1999
Colorectal cancer risk after colonoscopic polypectomy: a population-based study and literature search
2005
Long-Term Omeprazole Therapy Does Not Affect Helicobacter pylori Status in Most Patients
1993
Molecular, cytogenetic, and phenotypic studies of a constitutional reciprocal translocation t(5; I0)(q22; q25) responsible for familial adenomatous polyposis in a Dutch pedigree
1995
Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa
2000
Atrophic Gastritis andHelicobacter pyloriInfection in Patients with Reflux Esophagitis Treated with Omeprazole or Fundoplication
1996
Enhanced mucosal fibrinolytic activity in gastroduodenal ulcer haemorrhage and the beneficial effect of acid suppression
2001
CT Colonography and Colonoscopy: Assessment of Patient Preference in a 5-week Follow-up Study
2004
Efficacy of the H<sup>+</sup>/K<sup>+</sup>-Adenosine Triphosphatase Inhibitor Omeprazole in Peptic Ulcer
1989
Validation of the Rockall risk scoring system in upper gastrointestinal bleeding
1999
The effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: a randomized double-blind placebo-controlled multicentre study
1996
Prospective randomized open label blinded endpoint (PROBE) trial of high versus low dose mesalazine for prevention of relapse in patients with UC in remission
2001
Omeprazole improves outcome in peptic ulcer bleeding
1995
Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome.
1997
H. pylori eradication for chronic gastritis during omeprazole therapy for GERD
1998
Subject Index, Vol. 44, Supplement 1, 1989
1989
Rankless by CCL
2026